COMP <GO>
BTMD vs BON // RSI-14 & 200D SMA MOMENTUM
Biote Corp. (Class A) (NASDAQ) VS. Bon Natural Life Limited (Class A) (NASDAQ) • 15-METRIC TALLY: BTMD 6
— BON 1
▲ RSI-14 & 200D SMA MOMENTUM LEADER: BON
LAST: $1.17 (+1.74%) • MKT CAP: $42.0M
rsi-technicals
43.5
LAST: $1.13 (-0.01%) • MKT CAP: $9.2M
rsi-technicals
48.0
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BTMD VS. BON)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BTMD | BON | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 20.80% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 85.00% | — | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | 2.9x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | 1.46% | — | TIE | /fcf-yield <GO> |
| Operating Margin | 18.50% | -8.70% | +27.20 | BTMD | /operating-margins <GO> |
| Net Profit Margin | 14.10% | -10.70% | +24.80 | BTMD | /net-margins <GO> |
| Revenue Growth (YoY) | -2.50% | -21.70% | +19.20 | BTMD | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 4.11% | 0.00% | +4.11 | BTMD | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.50 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 3/9 | +3.00 | BTMD | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum ACTIVE | 43.5 | 48.0 | -4.45 | BON | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $42.0M | $9.2M | $32.9M | BTMD | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BTMD REV | BON REV | BTMD GROSS % | BON GROSS % | BTMD FCF | BON FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $192.2M | $18.7M | — | 20.8% | $30.2M | $134.3K |
| FY 2024 | $197.2M | $23.8M | — | 29.8% | $38.8M | -$7.7M |
| FY 2023 | $185.4M | $29.5M | — | — | $26.9M | -$616.9K |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BTMD // BETA —
BON // BETA —